Evidence map›Paper›PMID 30905399›Full record

ArticleAmerican journal of human genetics2019

De Novo Missense Substitutions in the Gene Encoding CDK8, a Regulator of the Mediator Complex, Cause a Syndromic Developmental Disorder.

Eduardo Calpena, Alexia Hervieu, Teresa Kaserer, Sigrid M A Swagemakers, Jacqueline A C Goos, Olajumoke Popoola, Maria Jesus Ortiz-Ruiz, Tina Barbaro-Dieber, Lucy Bownass, Eva H Brilstra and 21 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. A novel frameshift variant in theFrontiers in pediatrics · 2025
    Article
  10. Article
  11. Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Cochleovestibular Phenotype in a Rare Genetic MED13L Mutation.The journal of international advanced otology · 2024
    Article
  16. Article
  17. Pathogenic mutation hotspots in protein kinase domain structure.Protein science : a publication of the Protein Society · 2023
    Article
  18. Pathogenic variants in the paired-related homeobox 1 gene (PRRX1) cause craniosynostosis with incomplete penetrance.Genetics in medicine : official journal of the American College of Medical Genetics · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 3 countries.

Eduardo CalpenaClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Alexia HervieuCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK.
Teresa KasererCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK.
Sigrid M A SwagemakersDepartment of Pathology and Department of Bioinformatics, Erasmus University Medical Center, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Jacqueline A C GoosDepartment of Plastic and Reconstructive Surgery, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Olajumoke PopoolaCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK.
Maria Jesus Ortiz-RuizCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK.
Tina Barbaro-DieberGenetics Division, Cook Children's Medical Center, Fort Worth, TX 76102, USA.
Lucy BownassDepartment of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, St. Michael's Hospital, Bristol BS2 8EG, UK.
Eva H BrilstraDepartment of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands.
Elise BrimbleDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Nicola FouldsWessex Clinical Genetics Services, University Hospital Southampton, Southampton SO16 5YA, UK.
Theresa A GrebeDepartment of Child Health, University of Arizona College of Medicine, Division of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
Aster V E HarderDepartment of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands.
Melissa M LeesNorth Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3EH, UK.
Kristin G MonaghanGeneDx, Gaithersburg, MD 20877, USA.
Ruth A Newbury-EcobDepartment of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, St. Michael's Hospital, Bristol BS2 8EG, UK.
Kai-Ren OngDepartment of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.
Deborah OsioDepartment of Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.
Francis Jeshira Reynoso SantosGenetics Division, Joe DiMaggio Children's Hospital, Hollywood, FL 33021, USA; Charles E. Schmidt College of Medicine, Florida Atlantic University, Hollywood, FL 33021, USA.
Maura R Z RuzhnikovDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Aida TelegrafiGeneDx, Gaithersburg, MD 20877, USA.
Ellen van BinsbergenDepartment of Genetics, University Medical Center Utrecht, Utrecht University, 3508 AB Utrecht, the Netherlands.
Marieke F van DoorenDepartment of Clinical Genetics, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Deciphering Developmental Disorders StudyDeciphering Developmental Disorders Study, Wellcome Sanger Institute, Cambridge CB10 1SA, UK.
Peter J van der SpekDepartment of Pathology and Department of Bioinformatics, Erasmus University Medical Center, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Julian BlaggCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK.
Stephen R F TwiggClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Irene M J MathijssenDepartment of Plastic and Reconstructive Surgery, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.
Paul A ClarkeCancer Research UK Cancer Therapeutics Unit, the Institute of Cancer Research, London SM2 5NG, UK. Electronic address: paul.clarke@icr.ac.uk.
Andrew O M WilkieClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK. Electronic address: andrew.wilkie@imm.ox.ac.uk.
Erasmus MC · NLInstitute of Cancer Research · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBCancer Research UK · GBMRC Weatherall Institute of Molecular Medicine · GBStanford University · USUtrecht University · NLCook Children's Medical Center · USGreat Ormond Street Hospital for Children NHS Foundation Trust · GBJoe DiMaggio Children's Hospital · USPhoenix Children's Hospital · USSt Michaels Hospital · GBUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity Medical Center Utrecht · NLUniversity of Oxford · GB

Funding

Cancer Research UK C1362/A20263Wellcome Trust WT098051
6 · The paper itself

Abstract

The Mediator is an evolutionarily conserved, multi-subunit complex that regulates multiple steps of transcription. Mediator activity is regulated by the reversible association of a four-subunit module comprising CDK8 or CDK19 kinases, together with cyclin C, MED12 or MED12L, and MED13 or MED13L. Mutations in MED12, MED13, and MED13L were previously identified in syndromic developmental disorders with overlapping phenotypes. Here, we report CDK8 mutations (located at 13q12.13) that cause a phenotypically related disorder. Using whole-exome or whole-genome sequencing, and by international collaboration, we identified eight different heterozygous missense CDK8 substitutions, including 10 shown to have arisen de novo, in 12 unrelated subjects; a recurrent mutation, c.185C>T (p.Ser62Leu), was present in five individuals. All predicted substitutions localize to the ATP-binding pocket of the kinase domain. Affected individuals have overlapping phenotypes characterized by hypotonia, mild to moderate intellectual disability, behavioral disorders, and variable facial dysmorphism. Congenital heart disease occurred in six subjects; additional features present in multiple individuals included agenesis of the corpus callosum, ano-rectal malformations, seizures, and hearing or visual impairments. To evaluate the functional impact of the mutations, we measured phosphorylation at STAT1-Ser727, a known CDK8 substrate, in a CDK8 and CDK19 CRISPR double-knockout cell line transfected with wild-type (WT) or mutant CDK8 constructs. These experiments demonstrated a reduction in STAT1 phosphorylation by all mutants, in most cases to a similar extent as in a kinase-dead control. We conclude that missense mutations in CDK8 cause a developmental disorder that has phenotypic similarity to syndromes associated with mutations in other subunits of the Mediator kinase module, indicating probable overlap in pathogenic mechanisms.

Indexed as

Mutation, MissenseBrainChildChild, PreschoolCyclin CCyclin-Dependent Kinase 8Cyclin-Dependent KinasesDevelopmental DisabilitiesExomeFemaleHeart Defects, CongenitalHeterozygoteHumansInfantIntellectual DisabilityMaleCCNC protein, humanCDK8 protein, humanCyclin CCyclin-Dependent Kinase 8Cyclin-Dependent KinasesMediator Complexbehavioral disorderCDK8congenital heart diseasede novo mutationdominant negativehypotoniaintellectual disabilitykinaseMediator complexMediator kinase modulopathy

Identifiers

PMID30905399
PMCPMC6451695
OpenAlexW2924783892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.